Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Sales | 47,313 | 48,602 | 32,726 | 2,966 | 7,028 |
Cost of Goods | 2,087 | 2,756 | 3,630 | -2,110 | 1,910 |
Gross Profit | 45,226 | 45,846 | 29,096 | -7,380 | 5,110 |
Operating Expenses | 59,799 | 48,972 | 19,512 | 72,330 | 12,030 |
Operating Income | -14,486 | -2,370 | 10,214 | -67,364 | -6,002 |
Interest Expense | 0 | 0 | 259 | 6,570 | 1,480 |
Other Income | -6,287 | -5,981 | 12,165 | 44,104 | -2,588 |
Pre-tax Income | -20,773 | -8,351 | 22,120 | -29,830 | -10,070 |
Income Tax | 7,302 | 8,507 | 10,473 | 1,900 | -20 |
Net Income Continuous | -28,075 | -16,858 | 11,647 | -31,884 | -10,046 |
Net Income Discontinuous | N/A | N/A | N/A | 4,735 | 0 |
Net Income | $-28,075 | $-16,858 | $11,647 | $-27,149 | $-10,046 |
EPS Basic Total Ops | -0.69 | -0.42 | 0.29 | -0.69 | -0.26 |
EPS Basic Continuous Ops | -0.69 | -0.42 | 0.29 | -0.81 | -0.26 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.12 | N/A |
EPS Diluted Total Ops | -0.69 | -0.42 | 0.27 | -0.69 | -0.26 |
EPS Diluted Continuous Ops | -0.69 | -0.42 | 0.27 | -0.81 | -0.26 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.12 | N/A |
EBITDA(a) | $-11,217 | $901 | $13,474 | $-63,854 | $-2,582 |